Hookipa pharma reports quarterly loss per share of 43 cents

Hookipa pharma reports first quarter 2020 financial results and provides a corporate update.q1 revenue $3.7 million versus refinitiv ibes estimate of $4.2 million.revenue was $3.7 million for three months ended march 31, 2020 compared to $2.2 million for three months ended march 31, 2019.cash, cash equivalents and restricted cash as of march 31, 2020 was $104.9 million compared to $113.6 million as of december 31, 2019.qtrly loss per share $0.43.hookipa pharma - with about $105 million in cash,cash equivalents, believe are well funded beyond multiple clinical data points across our programs.
SY Ratings Summary
SY Quant Ranking